Navigation Links
Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing

HAYWARD, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced the appointment of Jeffrey C. Nardoci, as its Vice President of Global Marketing. Mr. Nardoci brings more than 19 years of experience in marketing and strategic consumer development in both the medical and consumer goods markets. At Solta Medical, he will focus on building the Company's brands, driving consumer awareness and developing marketing programs to enhance sales efforts. He will report to Clint Carnell, Chief Operating Officer of Solta Medical.

"Jeff has a proven track record of generating sales and increasing market share at leading multinational corporations," said Mr. Carnell. "In his most recent position as Vice President of Commercial Operations, U.S. Vision Care with Bausch & Lomb, he was responsible for a $530 million portfolio of lens, lens care and OTC pharmaceuticals. Jeff brings a wealth of marketing and management experience to our Company and we believe he will be a very strong contributor to Solta."

Mr. Nardoci spent 11 years at Bausch & Lomb in increasingly responsible positions. Prior to Bausch & Lomb, he was an executive consultant at Meridian Euro RSCG, a sales and marketing consulting group. His experience also includes seven years at Nabisco in the specialty foods marketing organization. Mr. Nardoci has a B.A. in Economics from Fairleigh Dickinson University.

"This is a very exciting time to join Solta Medical," said Mr. Nardoci. "The Company has established itself as a well-respected, innovative leader in the aesthetics industry and is poised for continued growth. There are significant opportunities to extend awareness of the company's Thermage® and Fraxel® brands, implement new marketing programs and help drive sales. I look forward to working with the entire Solta team."


Solta Medical is a global leader in the medical aesthetics market providing innovative, safe and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians.

The company offers products to address aging skin under the industry's two premier brands: Thermage® and Fraxel®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, over one million Thermage and Fraxel procedures have been performed in nearly 80 countries.

Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to

SOURCE Solta Medical, Inc.

SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
2. Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
3. Solta Medical, Inc. Announces Preliminary Financial Results for the Fourth Quarter of 2008
4. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
5. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
6. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
7. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting
8. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
11. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
Post Your Comments:
(Date:10/13/2017)... ... , ... As health professionals work to improve their approach to healthcare, there ... more than filling out a survey; in many cases health professionals and patients are ... care and research on the importance of active engagement with patients and members of ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
Breaking Medicine Technology: